Dr. Yvette Drew
Claim this profileGSK Investigational Site
Studies Tumors
Studies Sarcoma
2 reported clinical trials
3 drugs studied
Area of expertise
1Tumors
Stage IV
Stage III
MMR positive
2Sarcoma
Stage IV
Stage III
CYP2D6 positive
Affiliated Hospitals
Clinical Trials Yvette Drew is currently running
LY2880070
for Cancer
This trial is testing a new medication called LY2880070 in patients with advanced or spreading solid tumors to see if it can help control their tumor growth.
Recruiting1 award Phase 1 & 218 criteria
Dostarlimab
for Advanced Cancer
This trial is testing dostarlimab, a medicine that helps the immune system fight cancer, in patients with advanced solid tumors who have limited treatment options. It works by blocking a protein that allows cancer cells to hide from the immune system. Dostarlimab has garnered extensive interest for its ability to activate the immune system to respond to cancer cells.
Recruiting1 award Phase 110 criteria
More about Yvette Drew
Clinical Trial Related8 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Yvette Drew has experience with
- Dostarlimab
- Gemcitabine
- LY2880070
Breakdown of trials Yvette Drew has run
Sarcoma
Colorectal Cancer
Colon Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yvette Drew specialize in?
Yvette Drew focuses on Tumors and Sarcoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Yvette Drew currently recruiting for clinical trials?
Yes, Yvette Drew is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Yvette Drew has studied deeply?
Yes, Yvette Drew has studied treatments such as Dostarlimab, Gemcitabine, LY2880070.
What is the best way to schedule an appointment with Yvette Drew?
Apply for one of the trials that Yvette Drew is conducting.
What is the office address of Yvette Drew?
The office of Yvette Drew is located at: BC Cancer Agency, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BC Cancer Agency.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.